Improved Strains and Plasmid Vectors for Conditional Overexpression of His-Tagged Proteins in Haloferax volcanii

Research into archaea will not achieve its full potential until systems are in place to carry out genetics and biochemistry in the same species. Haloferax volcanii is widely regarded as the best-equipped organism for archaeal genetics, but the development of tools for the expression and purification of H. volcanii proteins has been neglected. We have developed a series of plasmid vectors and host strains for conditional overexpression of halophilic proteins in H. volcanii. The plasmids feature the tryptophan-inducible p.tnaA promoter and a 6×His tag for protein purification by metal affinity chromatography. Purification is facilitated by host strains, where pitA is replaced by the ortholog from Natronomonas pharaonis. The latter lacks the histidine-rich linker region found in H. volcanii PitA and does not copurify with His-tagged recombinant proteins. We also deleted the mrr restriction endonuclease gene, thereby allowing direct transformation without the need to passage DNA through an Escherichia coli dam mutant.Over the past century, our understanding of fundamental biological processes has grown exponentially, and this would have been impossible without the use of organisms that are amenable to experimental manipulation. Model species, such as Escherichia coli, Saccharomyces cerevisiae, Caenorhabditis elegans, Drosophila melanogaster, Mus musculus, and Arabidopsis thaliana, have become a byword for scientific progress (15). The rational choice of a model organism is critically important, and certain features are taken for granted, such as ease of cultivation, a short generation time, and systems for genetic manipulation. This list has now grown to include a genome sequence and methods for biochemical analysis of purified proteins in vitro.Research into archaea has lagged behind work on bacteria and eukaryotes but has nonetheless yielded profound insights (2). One hurdle has been the paucity of archaeal organisms suitable for both biochemistry and genetics. For example, Methanothermobacter thermautotrophicus is a stalwart of archaeal biochemistry but has proved resistant to even the most rudimentary genetic manipulation (2). Progress has recently been made with another biochemical workhorse, Sulfolobus spp., and a few genetic tools are now available (6, 13, 37). Methanosarcina spp. and Thermococcus kodakaraensis offer alternative systems with an increasing array of techniques (16, 35, 36), but sophisticated genetics has traditionally been the preserve of haloarchaea, of which Haloferax volcanii is the organism of choice (39). It is easy to culture, the genome has been sequenced (19), and there are several selectable markers and plasmids for transformation and gene knockout (3, 7, 31), including a Gateway system (14), as well as reporter genes (20, 33) and a tightly controlled inducible promoter (26).The genetic prowess of H. volcanii is not yet fully matched by corresponding systems for protein overexpression and purification. Like other haloarchaea, H. volcanii grows in high salt concentrations (2 to 5 M NaCl), and to cope with the osmotic potential of such environments, it accumulates high intracellular concentrations of potassium ions (12). Consequently, halophilic proteins are adapted to function at high salt concentrations and commonly feature a large excess of acidic amino acids; the negative surface charge is thought to be critical to solubility (28). This can pose problems for expression in heterologous hosts, such as E. coli, since halophilic proteins can misfold and aggregate under conditions of low ionic strength. The purification of misfolded halophilic enzymes from E. coli has relied on the recovery of insoluble protein from inclusion bodies, followed by denaturation and refolding in hypersaline solutions (8, 11). This approach is feasible only where the protein is well characterized and reconstitution of the active form can be monitored (for example, by an enzymatic assay). Furthermore, archaeal proteins expressed in heterologous bacterial hosts lack posttranslational modifications, such as acetylation or ubiquitination (4, 22), which are critical to understanding their biological function.Systems for expression of halophilic proteins in a native haloarchaeal host are therefore required. A number of studies have successfully purified recombinant proteins with a variety of affinity tags after overexpression in H. volcanii. For example, Humbard et al. employed tandem affinity tagging to purify 20S proteasomal core particles from the native host (23). However, the protein expression constructs used in these studies were custom made and somewhat tailored to the application in question. We report here the development of “generic” plasmid vectors and host strains for conditional overexpression of halophilic proteins in H. volcanii. The plasmids feature a tryptophan-inducible promoter derived from the tnaA gene of H. volcanii (26). We demonstrate the utility of these vectors by overexpressing a hexahistidine-tagged recombinant version of the H. volcanii RadA protein. Purification was greatly facilitated by a host strain in which the endogenous pitA gene was replaced by an ortholog from Natronomonas pharaonis. The latter protein lacks the histidine-rich linker region found in H. volcanii PitA (5) and therefore does not copurify with His-tagged recombinant proteins. Finally, we deleted the mrr gene of H. volcanii, which encodes a restriction enzyme that cleaves foreign DNA methylated at GATC residues. The mrr deletion strain allows direct transformation of H. volcanii without the need to passage plasmid DNA through an E. coli dam mutant (21).     

Whole-genome immunoinformatic analysis of F. tularensis: predicted CTL epitopes clustered in hotspots are prone to elicit a T-cell response

The cellular arm of the immune response plays a central role in the defense against intracellular pathogens, such as F. tularensis. To date, whole genome immunoinformatic analyses were limited either to relatively small genomes (e.g. viral) or to preselected subsets of proteins in complex pathogens. Here we present, for the first time, an unbiased bacterial global immunoinformatic screen of the 1740 proteins of F. tularensis subs. holarctica (LVS), aiming at identification of immunogenic peptides eliciting a CTL response. The very large number of predicted MHC class I binders (about 100,000, IC(50) of 1000 nM or less) required the design of a strategy for further down selection of CTL candidates. The approach developed focused on mapping clusters rich in overlapping predicted epitopes, and ranking these "hotspot" regions according to the density of putative binding epitopes. Limited by the experimental load, we selected to screen a library of 1240 putative MHC binders derived from 104 top-ranking highly dense clusters. Peptides were tested for their ability to stimulate IFNγ secretion from splenocytes isolated from LVS vaccinated C57BL/6 mice. The majority of the clusters contained one or more CTL responder peptides and altogether 127 novel epitopes were identified, of which 82 are non-redundant. Accordingly, the level of success in identification of positive CTL responders was 17-25 fold higher than that found for a randomly selected library of 500 predicted MHC binders (IC(50) of 500 nM or less). Most proteins (ca. 2/3) harboring the highly dense hotspots are membrane-associated. The approach for enrichment of true positive CTL epitopes described in this study, which allowed for over 50% increase in the dataset of known T-cell epitopes of F. tularensis, could be applied in immunoinformatic analyses of many other complex pathogen genomes.     

Generation of a novel anti-geldanamycin antibody

Geldanamycin (GA) and herbimycin A are benzoquinone ansamycins (BAs) that inhibit the molecular chaperone HSP90. The central role of HSP90 in maintaining the conformation, stability, and function of key oncogenic proteins involved in signal transduction pathways renders BAs attractive candidates for clinical development. Two GA derivatives, 17-allylamino-17-demethoxygeldanamycin and 17-demethoxy-17-N,N-dimethylaminoethylamino-geldanamycin are currently evaluated in clinical trials. The present study demonstrates generation of a polyclonal antibody elicited against GA that was conjugated to keyhole limpet hemocyanin via its 17 position. The anti-GA antibody recognizes GA as well as other BAs, suggesting its possible application for monitoring plasma levels of GA derivatives. The specificity of the antibody towards BAs is demonstrated by its inability to recognize radicicol, an HSP90 inhibitor not related to BAs. This antibody thus presents a novel research tool as well as a possible alternative approach for monitoring drug levels in patients.     

Argonaute 2/RISC resides in sites of mammalian mRNA decay known as cytoplasmic bodies

RNA interference (RNAi) is an important means of eliminating mRNAs, but the intracellular location of RNA-induced silencing complex (RISC) remains unknown. We show here that Argonaute 2, a key component of RISC, is not randomly distributed but concentrates in mRNA decay centres that are known as cytoplasmic bodies. The localization of Argonaute 2 in decay centres is not altered by the presence or absence of small interfering RNAs or their targeted mRNAs. However, RNA is required for the integrity of cytoplasmic bodies because RNase eliminates Argonaute 2 localization. In addition, Argonaute 1, another Argonaute family member, is concentrated in cytoplasmic bodies. These results provide new insight into the mechanism of RNAi function.     

Combination of Sleeping Beauty transposition and chemically induced dimerization selection for robust production of engineered cells

The main methods for producing genetically engineered cells use viral vectors for which safety issues and manufacturing costs remain a concern. In addition, selection of desired cells typically relies on the use of cytotoxic drugs with long culture times. Here, we introduce an efficient non-viral approach combining the Sleeping Beauty (SB) Transposon System with selective proliferation of engineered cells by chemically induced dimerization (CID) of growth factor receptors. Minicircles carrying a SB transposon cassette containing a reporter transgene and a gene for the F36VFGFR1 fusion protein were delivered to the hematopoietic cell line Ba/F3. Stably-transduced Ba/F3 cell populations with >98% purity were obtained within 1 week using this positive selection strategy. Copy number analysis by quantitative PCR (qPCR) revealed that CID-selected cells contain on average higher copy numbers of transgenes than flow cytometry-selected cells, demonstrating selective advantage for cells with multiple transposon insertions. A diverse population of cells is present both before and after culture in CID media, although site-specific qPCR of transposon junctions show that population diversity is significantly reduced after selection due to preferential expansion of clones with multiple integration events. This non-viral, positive selection approach is an attractive alternative for producing engineered cells.     

Quantitative behavior of B-lymphocytes in infection susceptible children following a single therapeutic substitution with human gamma globulin]

In 15 children with a lowered gammaglobulin level a single substitution with HGG was made, with the impact of this substitution on the number of B-cells in the peripheral blood being examined by means of the direct fluorescence antibody technique. In 9 from 15 children the substitution had no influence on the number of B-cells. However, a significant increase of the number of B-cells could be observed in 6 from 15 children. 14 days after the substitution the number of B-cells lay within the normal range again.     

5-Azacytidine permits gene activation in a previously noninducible cell type

We previously reported that silent muscle genes in fibroblasts could be activated following fusion with muscle cells to form heterokaryons. This activation did not require changes in chromatin structure involving significant DNA synthesis. We report here that muscle gene activation was never observed when HeLa cells were used as the nonmuscle fusion partner. However, if HeLa cells were treated with 5-azacytidine (5-aza-CR) prior to fusion, muscle gene expression was induced in the heterokaryons. The genes for both an early (5.1H11 cell surface antigen) and a late (MM-creatine kinase) muscle function were activated, but were frequently not coordinately expressed. These results suggest that the expression of two muscle genes, which is usually sequential, is not interdependent. Furthermore, changes induced by 5-aza-CR, presumably in the level of DNA methylation, are required for muscle genes in HeLa cells to be expressed in response to putative trans-acting regulatory factor(s) present in muscle cells.